{"id":"NCT03479307","sponsor":"Faes Farma, S.A.","briefTitle":"A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.","officialTitle":"A Multi-Center, Double-Masked, Randomized, Vehicle- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Bilastine Ophthalmic Solution 0.6% Compared to Vehicle and Zaditen (Ketotifen Ophthalmic Solution 0.025%) for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-07","primaryCompletion":"2018-08-09","completion":"2018-08-10","firstPosted":"2018-03-27","resultsPosted":"2021-12-14","lastUpdate":"2023-03-16"},"enrollment":228,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Bilastine Ophthalmic Solution 0.6%","otherNames":[]},{"type":"DRUG","name":"Ketotifen Ophthalmic Solution 0.025% (Zaditen)","otherNames":["Zaditen"]},{"type":"DRUG","name":"Vehicle of Bilastine Ophthalmic Solution","otherNames":[]}],"arms":[{"label":"Bilastine Ophthalmic Solution 0.6%","type":"EXPERIMENTAL"},{"label":"Ketotifen Ophthalmic Solution 0.025% (Zaditen)","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle of Bilastine Ophthalmic Solution","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of Bilastine ophthalmic solution 0.6% compared to vehicle and Zaditen (Ketotifen ophthalmic solution 0.025%) for the treatment of the signs and symptoms of allergic conjunctivitis.","primaryOutcome":{"measure":"Ocular Itching","timeFrame":"The outcome measure was assessed at Visit 4b (Day 1: 16h post-treatment) and Visit 5 (Day 8 ±3, 15 minutes post-treatment).","effectByArm":[{"arm":"Bilastine Ophthalmic Solution 0.6%","deltaMin":1.609,"sd":0.9013},{"arm":"Ketotifen Ophthalmic Solution 0.025% (Zaditen)","deltaMin":1.886,"sd":0.9504},{"arm":"Vehicle of Bilastine Ophthalmic Solution","deltaMin":2.219,"sd":0.9644}],"pValues":[{"comp":"OG000 vs OG002","p":"< 0.0001"},{"comp":"OG000 vs OG002","p":"< 0.0001"},{"comp":"OG001 vs OG002","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"0.0007"},{"comp":"OG000 vs OG001","p":"0.0002"},{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["36811846"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":91},"commonTop":["Visual Acuty Reduced","Conjunctivitis","Hordeolum","Sinusitis","Tooth Abscess"]}}